NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
 

CME Course Description

Login to view
Course Activities.



Speaker
Jan Basile, MD

Speaker Affiliation
Jan Basile, MD
Professor of Medicine
Seinsheimer Cardiovascular Health Program
Medical University of South Carolina
Ralph H. Johnson VA Medical Center
Charleston, SC

Registration for this expired course is open for zero credits.

Title:
Novel Pharmacologic Advances for the Treatment of Hypercholesterolemia to Reduce LDL Levels in Patients Who Are Responsive and Refractory to Statin Therapy
Activity/Course #:
ACME104


Cost:
Free
Release/Start Date:
Feb 02 2015
Expiration Date:
Feb 01 2017
Topics:
Primary Care Medicine
Target Audience:
Primary Care Providers
Medium/Method:
Webcast
Estimated Time To Complete CME Activity:
1.0 Hour
Hardware/Software Requirements:
Internet Explorer, Firefox and Safari browsers (Chrome not supported at this time)
Credit(s):
0

Welcome to the ABC webcast that was recorded at NACE Emerging Challenges in Primary Care 2014 conference in San Diego, CA. The topic of this webcast is Evidence Based Guideline Update: Novel Pharmacologic Advances for the Treatment of Hypercholesterolemia to Reduce LDL Levels in Patients Who Are Responsive and Refractory to Statin Therapy.


Learning Objective(s):
After completing this program participants should be able to:

  1. Identify concepts of residual cardiovascular risk despite statin therapy.
  2. Review the role of genetics in statin efficacy.
  3. Understand identification of minority populations that would benefit from lipid lowering therapy.
  4. Discuss the role of novel therapies to lower LDL and treat other lipid disorders.

How To Obtain Your CME Certificate

  1. Register for the course at http://naceonline.com/ABC-CME-Courses/index.php
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 60% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Association of Black Cardiologists is designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Faculty Disclosure Policy
The Association of Black Cardiologists (ABC) requires faculty, planners, managers, staff and other individuals who are in a position to control the content of CME activities to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ABC for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content and appropriateness of patient care recommendations. Faculty disclosures will be provided in activity materials.

Jan Basile, MD, Speaker, has the following relationships to disclose: Consultant for Lilly and Medtronic; Speaker for Arbor.

Cassandra McCullough, Activity Planning Committee, has no relationships to disclose.

Walter Wolyniec, MSc., Activity Planning Committee, has no relationships to disclose.

Gregg Sherman, MD, Course Director, has no relationships to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has the following relationships to disclose: co-owner of Specialty Press, Inc. and Health Link Systems, Inc.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.

Sheila Lucas, CWEP, Activity Planning Committee, has no relationships to disclose.

Cheryl C. Kay, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This educational activity is supported by an educational grant from sanofi-aventis U.S. and Regeneron Pharmaceuticals.